NMT Medical (Boston) said its StarFlex device did not achieve its primary endpoint in the company's CLOSURE I trial for patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results